Literature DB >> 28257675

Equinus and Lengthening Techniques.

Patrick A DeHeer1.   

Abstract

Equinus is linked to most lower extremity biomechanically related disorders. Defining equinus as ankle joint dorsiflexion less than 5° of dorsiflexion with the knee extended is the basis for evaluation and management of the deformity. Consistent evaluation methodology using a goniometer with the subtalar joint in neutral position and midtarsal joint supinated while dorsiflexing the ankle with knee extended provides a consistent clinical examination. For equinus deformity with an associated disorder, comprehensive treatment mandates treatment of the equinus deformity. Surgical treatment of equinus offers multiple procedures but the Baumann gastrocnemius recession is preferred based on deformity correction without weakness.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Achilles; Baumann; Bracing; Equinus; Gastrocsoleal complex; Strayer; Stretching; Tendo-Achilles lengthening

Mesh:

Year:  2017        PMID: 28257675     DOI: 10.1016/j.cpm.2016.10.008

Source DB:  PubMed          Journal:  Clin Podiatr Med Surg        ISSN: 0891-8422            Impact factor:   1.231


  3 in total

1.  Anatomical basis of a safe mini-invasive technique for lengthening of the anterior gastrocnemius aponeurosis.

Authors:  Simone Moroni; Alejandro Fernández-Gibello; Gabriel Camunas Nieves; Ruben Montes; Marit Zwierzina; Teresa Vazquez; Maria Garcia-Escudero; Fabrice Duparc; Bernhard Moriggl; Marko Konschake
Journal:  Surg Radiol Anat       Date:  2020-07-23       Impact factor: 1.246

2.  Defining Equinus Foot in Cerebral Palsy.

Authors:  Axel Horsch; Lara Petzinger; Maher Ghandour; Cornelia Putz; Tobias Renkawitz; Marco Götze
Journal:  Children (Basel)       Date:  2022-06-25

3.  Needle-based gastrocnemius lengthening: a novel ultrasound-guided noninvasive technique.

Authors:  Álvaro Iborra Marcos; Manuel Villanueva Martínez; Homid Fahandezh-Saddi Díaz
Journal:  J Orthop Surg Res       Date:  2022-09-29       Impact factor: 2.677

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.